Skip to content
OXGENE - TESSA Tech Overview

OXGENE - TESSA Tech Overview

OXGENE TESSA Technology Overview

TESSA™ technology addresses the industry-wide challenge of robust, reproducible, and scalable AAV manufacture, while avoiding the costs and bottlenecks of GMP plasmid-based production.

TESSA™ vectors can provide high quality help for AAV manufacture, but unlike the wildtype virus, they cannot produce adenoviral structural proteins. This reduces adenoviral contamination by 99.9999 - 100% in a manufacturing run, while also delivering high viral yields at a considerably lower cost than three-plasmid-transfection. Increased vector quality and infectivity also raises the potential of delivering safer gene therapies at a lower effective dose...

Download our free resource now.

We use cookies to give you the best experience of using this website. By continuing to use this site, you accept our use of cookies. Please read our Cookie Policy for more information.

Our single technology platform that fully connects our smart labs with our customer service proposition.


Connex revolutionises DNA design, optimization and assembly by ensuring the highest levels of quality control, efficiency and project management available for any client.

OXGENE has fully integrated all its smart labs and robotic production processes within a single technology platform that allows real-time project updates for our customers.